Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
WSU study first
WSU study first to determine best method of preclinical testing for alcohol use disorder medications
Nightmare bacteria
«Nightmare bacteria» cases on the rise in the US: CDC
NRx Pharmaceuticals
NRx Pharmaceuticals Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
Akari Therapeutics
Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1
Breakthrough Therapy Designation To Povetacicept
Vertex: FDA Grants Breakthrough Therapy Designation To Povetacicept
IGC Pharma
IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology
Autism Symptoms in Kids
FDA to Approve New Use of Cancer Drug for Autism Symptoms in Kids
Hanmi
Hanmi Reveals Promising Preclinical Results for Obesity Drug
Astellas’ Izervay
Astellas’ Izervay gains conditional approval in Japan for GA treatment
Pfizer buys monthly GLP-1RA
Pfizer buys monthly GLP-1RA developer Metsera for up to $4.9bn
Sanofi's
FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
Barth syndrome
FDA clears first treatment for rare male genetic disorder, Barth syndrome
2
3
4
5
6
7
8
9
10
